Alamar Bio

formerly Alamar BiosciencesIPO

Powering Precision Proteomics.

Public · Fremont, United States · Founded 2018 · $258.3M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$258.3M
Last Round
Series AJan 2026
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Alamar Biosciences (also known as Alamar Bio) is a precision proteomics life sciences company headquartered in Fremont, California, founded in 2018. The company's mission is to power precision proteomics to enable the earliest detection of disease. Alamar's core innovation, the NULISA technology platform, enables ultra-high sensitivity and high specificity analysis of hundreds of protein biomarkers from as little as 10 microliters of biofluid in a single sample. Products include the ARGO HT System and a growing portfolio of NULISAseq and NULISAqpcr assay panels spanning immunology, neurology, and oncology indications. The company filed for an IPO on Nasdaq in early 2026 targeting a $100M raise, having achieved $74M in revenue with 195% year-over-year growth.

Summary

Alamar Bio is a Biotech company based in Fremont, United States, founded in 2018. It has raised $258.3M in total across 6 rounds, most recently a Series A round in Jan 2026. Investors include Illumina Ventures, Qiming VP and Sands Capital.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOApr 2026
$191.3M

Sign up to see all 7 events

Funding: Series A through Convertible Note. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare
Private EquityTotal funding$3.3BApr 2022
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alamar Bio on Indexed.vc
<a href="https://indexed.vc/companies/alamar-bio"><img src="https://indexed.vc/api/badge/company/alamar-bio" alt="Alamar Bio on Indexed.vc" width="260" height="76" /></a>